| Symbol |
Name |
|
ADAM19
|
ADAM metallopeptidase domain 19
|
|
AIM1
|
absent in melanoma 1
|
|
ALCAM
|
activated leukocyte cell adhesion molecule
|
|
ANXA2
|
annexin A2
|
|
APC
|
adenomatous polyposis coli
|
|
APOE
|
apolipoprotein E
|
|
BASP1
|
brain abundant, membrane attached signal protein 1
|
|
BCL11A
|
B-cell CLL/lymphoma 11A (zinc finger protein)
|
|
CCND1
|
cyclin D1
|
|
CCND3
|
cyclin D3
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CTSG
|
cathepsin G
|
|
DTX1
|
deltex 1, E3 ubiquitin ligase
|
|
ENTPD1
|
ectonucleoside triphosphate diphosphohydrolase 1
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FUS
|
FUS RNA binding protein
|
|
GART
|
phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase
|
|
GSTO1
|
glutathione S-transferase omega 1
|
|
KLF6
|
Kruppel-like factor 6
|
|
LASP1
|
LIM and SH3 protein 1
|
|
LCN2
|
lipocalin 2
|
|
MARCKS
|
myristoylated alanine-rich protein kinase C substrate
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
NASP
|
nuclear autoantigenic sperm protein (histone-binding)
|
|
PKIG
|
protein kinase (cAMP-dependent, catalytic) inhibitor gamma
|
|
PRKCQ
|
protein kinase C, theta
|
|
PTPRE
|
protein tyrosine phosphatase, receptor type, E
|
|
RGS1
|
regulator of G-protein signaling 1
|
|
RUNX2
|
runt-related transcription factor 2
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
SAT1
|
spermidine/spermine N1-acetyltransferase 1
|
|
SEPP1
|
selenoprotein P, plasma, 1
|
|
SHMT1
|
serine hydroxymethyltransferase 1 (soluble)
|
|
SLC29A1
|
solute carrier family 29 (equilibrative nucleoside transporter), member 1
|
|
SMAD1
|
SMAD family member 1
|
|
STC2
|
stanniocalcin 2
|
|
STOM
|
stomatin
|
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa
|
|
TYMS
|
thymidylate synthetase
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VPREB3
|
pre-B lymphocyte 3
|